Actos Bladder Cancer Verdict in Favor of Plaintiff in Philadelphia
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. Things are heating up in Actos litigation, with defendant Takeda hit with another verdict rising from the use of the drug the development of bladder cancer. On February 12th, Takeda Pharmaceuticals Inc. was hit with a $2.3 million verdict after a
Read More$2.5m DePuy ASR Hip Verdict in Favor of Plaintiff in Tulsa Trial
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. A recent verdict in favor of the plaintiff reminded Johnson & Johnson that their worries (and financial exposure) over defective ASR hips revised post-settlement are not over. A jury in Tulsa County, Oklahoma on February 3rd returned a $2.5 million compensatory
Read More